The addition of the Pennsylvania provider's seven facilities boosts the Woodbridge-based outpatient orthopedic physical and occupational therapy services company's presence throughout Bucks County.

Jessica Moore will assume her new role on Nov. 1. She most recently served as vice president and CFO for the Janssen Pharmaceutical business.

Dr. Paul Stoffels will depart at the end of the year. His purview saw the establishment of J&J Innovation, or JLABS, which has more than 700 companies incubating today. He described his time at the New Brunswick-based company as "an honor and a privilege."

Ophelia Byers will also serve as associate chief nurse executive for Atlantic Health System. In her new roles she will partner with Trish O’Keefe, senior vice president and chief nurse executive for the organization and president of Morristown Medical Center, to align and support care across all clinical settings.

The nation’s top infectious disease expert pretty much reiterated Gov. Phil Murphy's stance on the holiday: “[E]njoy it, this is the time that children love,” adding that getting the COVID-19 vaccine ahead of the holiday is an “extra degree of protection.”

The 250,000-square-foot space offers advanced technology and automation to deliver quality lab results to physicians and patients in seven states.

Several medical cannabis business licenses will be doled out, putting an end to a two-year process that, without litigation, would have likely taken a handful of months.

The company plans to establish centers throughout underserved communities as a means to provide more cost-effective treatment to the most vulnerable patients.

Dr. Tia Welsh oversees the delivery of clinical services, including program development and strategic planning throughout the organization.

The CEO of University Hospital discusses his efforts to change the culture at the Newark institution, maintain its role in the community and, of course, whether New Jerseyans can celebrate the holidays safely this year.

Molnupiravir, an investigational oral medicine, has had positive results in its clinical trial. If authorized, it could be the first treatment of its kind for COVID-19.

With the holidays approaching, and the CDC's flub on issuing guidance for a socially distanced holiday season, that was since recalled, one thing is clear: COVID-19 will continue to be on people’s minds through the end of the year, and it has businesses and public health experts wary.